NCT00036101已完成3 期
Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar Disorder
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 试验地点
- 27
研究概览
简要总结
The purpose of this study is to learn if aripiprazole is effective for the treatment of patients with acute symptoms of Bipolar disorder.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with acute symptoms of Bipolar Disorder
排除标准
- 未提供
研究者
研究点 (27)
Loading locations...
相似试验
已完成
3 期
Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar DisorderBipolar I DisorderNCT00046384Otsuka Pharmaceutical Development & Commercialization, Inc.
已完成
3 期
Study of Aripiprazole in Patients With a History of Bipolar DisorderBipolar DisorderNCT00036348Otsuka Pharmaceutical Development & Commercialization, Inc.
已完成
3 期
Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's TypeAlzheimer DiseaseNCT00036114Otsuka Pharmaceutical Development & Commercialization, Inc.
已完成
3 期
Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's TypeAlzheimer DiseaseNCT00041678Otsuka Pharmaceutical Development & Commercialization, Inc.
已完成
4 期
Efficacy and Safety of Aripiprazole in First Episode PsychosisFirst Episode PsychosisNCT01026584Chonbuk National University Hospital55